40 likes | 125 Views
Regenerative medicine deals with the process of using therapeutically-induced or laboratory grown human tissue to treat diseased or injured human cells, tissues, or organs. It is an emerging field of treatment that helps in producing new cells to substitute malfunctioning or injured cells as a vehicle to treat disease and injury.
E N D
Hexa Reports Market Research Reports and Insightful Company Profiles US Regenerative Medicine Market Share, Size, Emerging Trends and Growth, Analysis, Overview and Forecasts 2016- 2020 Regenerative medicine deals with the process of using therapeutically-induced or laboratory grown human tissue to treat diseased or injured human cells, tissues, or organs. It is an emerging field of treatment that helps in producing new cells to substitute malfunctioning or injured cells as a vehicle to treat disease and injury. The regenerative medicine market can be characterized into three major modalities, namely tissue engineering, biomaterials/biomolecules, and stem cell therapy. Technavios market research analysts expect the regenerative medicine market in the US to grow at a fast pace, posting a remarkable CAGR of more than 33% during the forecast period because of the growing demand for tissue-engineered and stem cell products for the treatment of various diseases. The potential of these medicines in regenerating diseased organs is one of the major factors that drives the market in the US. The stem cells application and advancements in nanotechnology will further drive the progress in this market. Browse Detail Report With TOC @ http://hexareports.com/report/regenerative-medicine-market-in-the-us/details Segmentation by product and analysis of - cell therapy and scaffold Cell therapy helps in treating the diseases or to improving the functioning of the existing cells, by administrating of cells into the body. This therapy addresses medical conditions related to the bone,
Hexa Reports Market Research Reports and Insightful Company Profiles cartilage, heart, skin, digestive system, reproductive system, eye, blood, spine, brain, and the nervous system. In 2015, cell therapy segment accounted for approximately 80% of the market share. The report offers an analysis of each of the following segments and discusses its impact on the overall market growth - Cell therapy Scaffold Segmentation by application and analysis of - dermatology, musculoskeletal, ocular, and cardiovascular The year 2015 saw the precedence of the dermatology segment, accounting for a market share of more than 51%. Dermatology includes the treatment of burns and chronic wounds that requires a quick response, and skin grafting is essential in many cases. Factors such as the increase in obesity and diabetes, growing elderly population, and an increase in life expectancy are some of the causes contributing to the growth of the dermatology market. The report offers an analysis of each of the following segments and discusses its impact on the overall market growth – Dermatology Musculoskeletal Ocular Cardiovascular Request A Sample copy of This Report @ http://hexareports.com/sample/70640 Competitive landscape and key vendors - AkzoNobel, Jotun, PPG Regenerative medicine market in the US is highly competitive and fragmented because of the presence of several established vendors and this competitive environment is expected to intensify with advances in R&D and technological innovations. International players are likely to acquire regional or local players to enhance their products and expand their market share during the forecast period. The top vendors in the market are - Acelity Mesoblast Organogenesis Reprocell Stryker Other prominent vendors include Table Of Content PART 01: Executive summary Highlights
Hexa Reports Market Research Reports and Insightful Company Profiles PART 02: Scope of the report Market overview Top vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights PART 05: Gene therapy: An emerging field in regenerative medicine PART 06: Pipeline portfolio PART 07: Regulatory scenario FDA process PART 08: Market landscape Market overview Market size and forecast Five forces analysis Browse All Healthcare Market Research Related Reports @ http://hexareports.com/category/healthcare-market PART 09: Market segmentation by product Cell therapy Cell therapy market in US Scaffold Scaffold market in US PART 10: Market segmentation by application Dermatology Musculoskeletal Ocular Cardiovascular PART 11: Market drivers Rise in prevalence of chronic diseases Technological innovations Increase in investment for research and development activities PART 12: Impact of drivers PART 13: Market challenges Stringent regulatory approval process
Hexa Reports Market Research Reports and Insightful Company Profiles Ethical challenges Lack of clinical data PART 14: Impact of drivers and challenges PART 15: Market trends Increase in pipeline products Strategic alliances Potential of regenerative medicine toward decreasing healthcare costs PART 16: Vendor landscape Competitive scenario Key news Mergers and acquisitions Key vendor analysis 2015 Other prominent vendors PART 17: Key vendor analysis Acelity Mesoblast Organogenesis Reprocell Stryker Browse Full Report @ http://hexareports.com/report/regenerative-medicine-market-in-the-us/details About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/ Visit our Blog: http://hexareports.blogspot.com/